Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin

Authors:

Abstract
Neuroendocrine carcinomas are very aggressive tumors with few treatment options. DLL3 seems to be an optimal target for therapeutic intervention, as it is expressed mainly on the membrane of tumor ...

This publication has 63 references indexed in Scilit: